Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.

A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.

José Baselga of Memorial Sloan Kettering took millions of dollars from drug and health care companies but did not report the payments in his research articles.

The company’s announcement comes weeks after enrollment was suspended.

An email exchange and an unusual meeting suggest a connection between an institute’s pursuit of industry support and the rejection of a grant application.

The authors of two new studies on the payments suggest stricter guidelines are needed.

Agriculture faculty members allege funding from industry organizations is tied to their employment status.

Three investigations reveal the influence of industry money in patient advocacy groups, treatment guidelines, and Twitter feeds. 

What’s in store for commercialization grants at the Canadian Institutes of Health Research?

In times of budget belt-tightening at the federal level, life-science researchers can keep their work supported through private sources.
 

A leading scientific voice among global warming skeptics received funding from the energy industry while publishing claims that climate change is not driven by human activity.